Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 24, Iss. 28, 2017-09 ,pp. : 3054-3067

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives

By  

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 164-168

Bentham Science Publishers

Access to resources Recommend Favorite

The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives

By  

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1174-1183

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 45-59

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 818-832

Bentham Science Publishers

Access to resources Recommend Favorite